Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Magneto-liposomes as MRI contrast agents : a systematic study of different liposomal formulations
ID
Kostevšek, Nina
(
Author
),
ID
Cheung, Calvin C. L.
(
Author
),
ID
Serša, Igor
(
Author
),
ID
Erdani-Kreft, Mateja
(
Author
),
ID
Monaco, Ilaria
(
Author
),
ID
Comes Franchini, Mauro
(
Author
),
ID
Vidmar, Janja
(
Author
),
ID
Al-Jamal, Wafa T.
(
Author
)
PDF - Presentation file,
Download
(2,13 MB)
MD5: 6903C41690F1FFB7509684F1DB463CD4
URL - Source URL, Visit
https://www.mdpi.com/2079-4991/10/5/889
Image galllery
Abstract
The majority of the clinically approved iron oxide nanoparticles (IO NPs) used as contrast agents for magnetic resonance imaging (MRI) have been withdrawn from the market either due to safety concerns or lack of profits. To address this challenge, liposomes have been used to prepare IO-based T$_2$ contrast agents. We studied the influence of different phospholipids on the relaxivity (r$_2$) values of magneto-liposomes (MLs) containing magnetic NPs in the bilayer, where a strong correlation between the bilayer fluidity and r$_2$ is clearly shown. Embedding 5-nm IO NPs in the lipid bilayer leads to a significant improvement in their relaxivity, where r$_2$ values range from 153 ± 5 s$^{−1}$ mM$^{−1}$ for DPPC/cholesterol/DSPE-PEG (96/50/4) up to 673 ± 12 s$^{−1}$ mM$^{−1}$ for DOPC/DSPE-PEG (96/4), compared to “free” IO NPs with an r$_2$ value of 16 s$^{−1}$ mM$^{−1}$, measured at 9.4 T MRI scanner. In vitro MRI measurements, together with the ICP-MS analysis, revealed MLs as highly selective contrast agents that were preferentially taken up by cancerous T24 cells, which led to an improvement in the contrast and an easier distinction between the healthy and the cancerous cells. A careful selection of the lipid bilayer to prepare MLs could offer efficient MRI contrast agents, even at very low IO NP concentrations.
Language:
English
Keywords:
liposomes
,
magnetic resonance imaging
,
iron oxide
,
contrast agent
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2020
Number of pages:
18 str.
Numbering:
Vol. 10, iss. 5, art. 889
PID:
20.500.12556/RUL-133732
UDC:
537
ISSN on article:
2079-4991
DOI:
10.3390/nano10050889
COBISS.SI-ID:
14045955
Publication date in RUL:
13.12.2021
Views:
1384
Downloads:
145
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Nanomaterials
Shortened title:
Nanomaterials
Publisher:
MDPI
ISSN:
2079-4991
COBISS.SI-ID:
523286297
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
06.05.2020
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
Z2-9218
Name:
Razvoj večfunkcionalnih hibridnih liposomov za aktivno zdravljenje rakavih obolenj in večmodalno diagnostiko
Funder:
ARRS - Slovenian Research Agency
Project number:
P2-0084
Name:
Nanostrukturni materiali
Funder:
ARRS - Slovenian Research Agency
Project number:
J3-7494
Name:
Tunelske membranske nanocevke za inovativno zdravljenje raka sečnega mehurja
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0108
Name:
Diferenciacija urotelijskih celic
Funder:
Other - Other funder or multiple funders
Funding programme:
Prostate Cancer UK, Fellowship
Project number:
CDF-12-002
Funder:
RCUK - Research Council UK
Funding programme:
EPSRC
Project number:
EP/M008657/1
Name:
Engineering Multi-functional Nanomaterials to Treat Metastatic Cancer
Funder:
Other - Other funder or multiple funders
Funding programme:
University of Bologna, Marco Polo fellowship
Funder:
Other - Other funder or multiple funders
Funding programme:
COST
Project number:
CA 17140
Name:
Cancer Nanomedicine from the Bench to the Bedside
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back